top of page

CANCELLED - Immunotherapy for Patients with NSCLC Following Chemoradiation

Wed, Sep 12

|

Fleming’s Prime Steakhouse & Wine Bar

Indication: IMFINZI is indicated for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.

Registration is Closed as this event has been Cancelled
See other events
CANCELLED - Immunotherapy for Patients with NSCLC Following Chemoradiation
CANCELLED - Immunotherapy for Patients with NSCLC Following Chemoradiation

Time & Location

Sep 12, 2018, 6:15 PM

Fleming’s Prime Steakhouse & Wine Bar, 217 Stuart St, Boston, MA 02116, USA

Guests

About The Event

We regret to inform you this event has been cancelled.

To find out more information or to register for this meeting, please contact Susan Predaris at susan.predaris@astrazeneca.com or (603) 247-1306.

Share This Event

BONS logo.png

Contact:

Daunielle Ricardi, President

Alissa Gentile, Treasurer

Cameron Keith, Social Media Coordinator

Email: BonsSocialMedia@gmail.com

  • Facebook
  • Instagram
  • LinkedIn
Earthen Media-4.png
bottom of page